Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

18F-FDG PET/CT and Urothelial Carcinoma: Impact on Management and Prognosis-A Multicenter Retrospective Study.

Zattoni F, Incerti E, Dal Moro F, Moschini M, Castellucci P, Panareo S, Picchio M, Fallanca F, Briganti A, Gallina A, Fanti S, Schiavina R, Brunocilla E, Rambaldi I, Lowe V, Karnes JR, Evangelista L.

Cancers (Basel). 2019 May 20;11(5). pii: E700. doi: 10.3390/cancers11050700.

2.

Vertebral Fractures of Unknown Origin: Role of Computed Tomography-Guided Biopsy.

Spinnato P, Bazzocchi A, Facchini G, Filonzi G, Nanni C, Rambaldi I, Rimondi E, Fanti S, Albisinni U.

Int J Spine Surg. 2018 Dec 21;12(6):673-679. doi: 10.14444/5084. eCollection 2018 Dec.

3.

Automated Synthesis of 68Ga-DOTA-TOC with a Cationic Purification System: Evaluation of Methodological and Technical Aspects in Routine Preparations.

Uccelli L, Boschi A, Cittanti C, Martini P, Lodi L, Zappaterra E, Romani S, Zaccaria S, Cecconi D, Rambaldi I, Santi I, Panareo S, Giganti M, Bartolomei M.

Curr Radiopharm. 2018;11(2):130-137. doi: 10.2174/1874471011666180509101420.

PMID:
29745348
4.

Italian Multicenter Study on Accuracy of 18F-FDG PET/CT in Assessing Bone Marrow Involvement in Pediatric Hodgkin Lymphoma.

Cistaro A, Cassalia L, Ferrara C, Quartuccio N, Evangelista L, Bianchi M, Fagioli F, Bisi G, Baldari S, Zanella A, Pillon M, Zucchetta P, Burei M, Sala A, Guerra L, Guglielmo P, Burnelli R, Panareo S, Scalorbi F, Rambaldi I, Piccardo A, Garaventa A, Familiari D, Fornito MC, Lopci E, Mascarin M, Altini C, Ferrari C, Perillo T, Santoro N, Borsatti E, Rubini G.

Clin Lymphoma Myeloma Leuk. 2018 Jun;18(6):e267-e273. doi: 10.1016/j.clml.2018.04.002. Epub 2018 Apr 14.

PMID:
29739722
5.

Comparison between the diagnostic accuracies of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and conventional imaging in recurrent urothelial carcinomas: a retrospective, multicenter study.

Zattoni F, Incerti E, Colicchia M, Castellucci P, Panareo S, Picchio M, Fallanca F, Briganti A, Moschini M, Gallina A, Karnes JR, Lowe V, Fanti S, Schiavina R, Rambaldi I, Ficarra V, Evangelista L.

Abdom Radiol (NY). 2018 Sep;43(9):2391-2399. doi: 10.1007/s00261-017-1443-6.

PMID:
29302738
6.

MT3-MMP Promotes Excitatory Synapse Formation by Promoting Nogo-66 Receptor Ectodomain Shedding.

Sanz RL, Ferraro GB, Kacervosky J, Salesse C, Gowing E, Hua L, Rambaldi I, Beaubien F, Holmbeck K, Cloutier JF, Lévesque M, Murai K, Fournier AE.

J Neurosci. 2018 Jan 17;38(3):518-529. doi: 10.1523/JNEUROSCI.0962-17.2017. Epub 2017 Dec 1.

7.

RhoA Proteolysis Regulates the Actin Cytoskeleton in Response to Oxidative Stress.

Girouard MP, Pool M, Alchini R, Rambaldi I, Fournier AE.

PLoS One. 2016 Dec 19;11(12):e0168641. doi: 10.1371/journal.pone.0168641. eCollection 2016.

8.

18F-FDG PET/CT focal, but not osteolytic, lesions predict the progression of smoldering myeloma to active disease.

Zamagni E, Nanni C, Gay F, Pezzi A, Patriarca F, Bellò M, Rambaldi I, Tacchetti P, Hillengass J, Gamberi B, Pantani L, Magarotto V, Versari A, Offidani M, Zannetti B, Carobolante F, Balma M, Musto P, Rensi M, Mancuso K, Dimitrakopoulou-Strauss A, Chauviè S, Rocchi S, Fard N, Marzocchi G, Storto G, Ghedini P, Palumbo A, Fanti S, Cavo M.

Leukemia. 2016 Feb;30(2):417-22. doi: 10.1038/leu.2015.291. Epub 2015 Oct 22.

PMID:
26490489
9.

Image interpretation criteria for FDG PET/CT in multiple myeloma: a new proposal from an Italian expert panel. IMPeTUs (Italian Myeloma criteria for PET USe).

Nanni C, Zamagni E, Versari A, Chauvie S, Bianchi A, Rensi M, Bellò M, Rambaldi I, Gallamini A, Patriarca F, Gay F, Gamberi B, Cavo M, Fanti S.

Eur J Nucl Med Mol Imaging. 2016 Mar;43(3):414-21. doi: 10.1007/s00259-015-3200-9. Epub 2015 Oct 16.

PMID:
26475305
10.

PET/CT Improves the Definition of Complete Response and Allows to Detect Otherwise Unidentifiable Skeletal Progression in Multiple Myeloma.

Zamagni E, Nanni C, Mancuso K, Tacchetti P, Pezzi A, Pantani L, Zannetti B, Rambaldi I, Brioli A, Rocchi S, Terragna C, Martello M, Marzocchi G, Borsi E, Rizzello I, Fanti S, Cavo M.

Clin Cancer Res. 2015 Oct 1;21(19):4384-90. doi: 10.1158/1078-0432.CCR-15-0396. Epub 2015 Jun 15.

11.

FDG PET/CT in autoimmune pancreatitis.

Nanni C, Romagnoli R, Rambaldi I, Caroli P, Matteucci F, Ambrosini V, Re G, Fanti S.

Eur J Nucl Med Mol Imaging. 2014 Jun;41(6):1264-5. doi: 10.1007/s00259-014-2699-5. Epub 2014 Feb 22. No abstract available.

PMID:
24562645
12.

A powerful molecular engineering tool provided efficient Chlamydomonas mutants as bio-sensing elements for herbicides detection.

Lambreva MD, Giardi MT, Rambaldi I, Antonacci A, Pastorelli S, Bertalan I, Husu I, Johanningmeier U, Rea G.

PLoS One. 2013 Apr 17;8(4):e61851. doi: 10.1371/journal.pone.0061851. Print 2013.

13.

Neurite outgrowth is differentially impacted by distinct immune cell subsets.

Pool M, Rambaldi I, Darlington PJ, Wright MC, Fournier AE, Bar-Or A.

Mol Cell Neurosci. 2012 Jan;49(1):68-76. doi: 10.1016/j.mcn.2011.09.004. Epub 2011 Sep 22.

PMID:
21971580
14.

Myeloid lineage cells inhibit neurite outgrowth through a myosin II-dependent mechanism.

Pool M, Rambaldi I, Durafourt BA, Wright MC, Antel JP, Bar-Or A, Fournier AE.

J Neuroimmunol. 2011 Aug 15;237(1-2):101-5. doi: 10.1016/j.jneuroim.2011.06.004. Epub 2011 Jul 7.

PMID:
21737147
15.

Myelin regulates immune cell adhesion and motility.

Pool M, Niino M, Rambaldi I, Robson K, Bar-Or A, Fournier AE.

Exp Neurol. 2009 Jun;217(2):371-7. doi: 10.1016/j.expneurol.2009.03.014. Epub 2009 Mar 27.

PMID:
19328785
16.

Stereospecificity and PAX6 function direct Hoxd4 neural enhancer activity along the antero-posterior axis.

Nolte C, Rastegar M, Amores A, Bouchard M, Grote D, Maas R, Kovacs EN, Postlethwait J, Rambaldi I, Rowan S, Yan YL, Zhang F, Featherstone M.

Dev Biol. 2006 Nov 15;299(2):582-93. Epub 2006 Aug 30.

17.

MEIS C termini harbor transcriptional activation domains that respond to cell signaling.

Huang H, Rastegar M, Bodner C, Goh SL, Rambaldi I, Featherstone M.

J Biol Chem. 2005 Mar 18;280(11):10119-27. Epub 2005 Jan 15.

18.

Sequential histone modifications at Hoxd4 regulatory regions distinguish anterior from posterior embryonic compartments.

Rastegar M, Kobrossy L, Kovacs EN, Rambaldi I, Featherstone M.

Mol Cell Biol. 2004 Sep;24(18):8090-103.

19.

Subcellular localization of multiple PREP2 isoforms is regulated by actin, tubulin, and nuclear export.

Haller K, Rambaldi I, Daniels E, Featherstone M.

J Biol Chem. 2004 Nov 19;279(47):49384-94. Epub 2004 Aug 30.

20.

Expression of the Wdr9 gene and protein products during mouse development.

Huang H, Rambaldi I, Daniels E, Featherstone M.

Dev Dyn. 2003 Aug;227(4):608-14.

21.

Nonmuscle myosin promotes cytoplasmic localization of PBX.

Huang H, Paliouras M, Rambaldi I, Lasko P, Featherstone M.

Mol Cell Biol. 2003 May;23(10):3636-45.

22.

Prep2: cloning and expression of a new prep family member.

Haller K, Rambaldi I, Kovács EN, Daniels E, Featherstone M.

Dev Dyn. 2002 Nov;225(3):358-64.

23.
24.

PBX and MEIS as non-DNA-binding partners in trimeric complexes with HOX proteins.

Shanmugam K, Green NC, Rambaldi I, Saragovi HU, Featherstone MS.

Mol Cell Biol. 1999 Nov;19(11):7577-88.

25.
26.

Cooperative interactions between HOX and PBX proteins mediated by a conserved peptide motif.

Phelan ML, Rambaldi I, Featherstone MS.

Mol Cell Biol. 1995 Aug;15(8):3989-97.

27.

A proline-rich transcriptional activation domain in murine HOXD-4 (HOX-4.2).

Rambaldi I, Kovàcs EN, Featherstone MS.

Nucleic Acids Res. 1994 Feb 11;22(3):376-82.

28.

Myelin instability and oligodendrocyte metabolism in myelin-deficient mutant mice.

Matthieu JM, Roch JM, Omlin FX, Rambaldi I, Almazan G, Braun PE.

J Cell Biol. 1986 Dec;103(6 Pt 2):2673-82.

Supplemental Content

Loading ...
Support Center